المؤلفون: Amadesi S; Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Amedeo A; Clinical Infectious Diseases Unit IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rinaldi M; Clinical Infectious Diseases Unit IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Palombo M; Division of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Giannella M; Clinical Infectious Diseases Unit IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Gaibani P; Department of Diagnostic and Public Health, Microbiology Section, Verona University, Verona, Italy. Electronic address: paolo.gaibani@univr.it.

المصدر: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Sep; Vol. 110 (1), pp. 116372. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0070 (Electronic) Linking ISSN: 07328893 NLM ISO Abbreviation: Diagn Microbiol Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Klebsiella pneumoniae*/drug effects , Klebsiella pneumoniae*/genetics , Ceftazidime*/pharmacology , Ceftazidime*/therapeutic use , Azabicyclo Compounds*/pharmacology , Azabicyclo Compounds*/therapeutic use , Drug Combinations* , Klebsiella Infections*/drug therapy , Klebsiella Infections*/microbiology , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Cephalosporins*/therapeutic use , Cephalosporins*/pharmacology , Cefiderocol* , Drug Resistance, Multiple, Bacterial*/genetics , beta-Lactamases*/genetics , beta-Lactamases*/metabolism , Microbial Sensitivity Tests*, Humans ; Male ; Female ; Aged ; Middle Aged ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Point Mutation

المؤلفون: Lewis RE; Department of Molecular Medicine, University of Padova, 35122 Padova, Italy., Palombo M; IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40135 Bologna, Italy., Diani E; Department of Diagnostic and Public Health, Microbiology Section, Verona University, 37134 Verona, Italy., Secci B; IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40135 Bologna, Italy., Gibellini D; Department of Diagnostic and Public Health, Microbiology Section, Verona University, 37134 Verona, Italy., Gaibani P; Department of Diagnostic and Public Health, Microbiology Section, Verona University, 37134 Verona, Italy.

المصدر: Cells [Cells] 2024 Aug 06; Vol. 13 (16). Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Azabicyclo Compounds*/pharmacology , Tazobactam*/pharmacology , Sulbactam*/pharmacology , Drug Synergism* , Cephalosporins*/pharmacology , Microbial Sensitivity Tests* , Anti-Bacterial Agents*/pharmacology , Cefiderocol* , Gram-Negative Bacteria*/drug effects, Carbapenems/pharmacology ; Humans ; Acinetobacter baumannii/drug effects ; Pseudomonas aeruginosa/drug effects ; beta-Lactamase Inhibitors/pharmacology ; Drug Resistance, Multiple, Bacterial/drug effects ; Drug Combinations

المؤلفون: Zhan Y; Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China., Mao W; Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China., Zhao C; Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China., Lu D; Cardiovascular Ultrasound Center of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, China., Chen C; Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China., Hu W; Department of Critical Care Medicine, Zhejiang Hospital, Lingyin Road 12, Hangzhou, Zhejiang, 310013, China., Yang Q; Department of Respiratory, The First Hospital of Jiaxing (Affiliated Hospital of Jiaxing University), NO.1882, Nanhu District, Jiaxing, Zhejiang, 314000, China. yangqijxsy@163.com.

المصدر: BMC infectious diseases [BMC Infect Dis] 2024 Sep 13; Vol. 24 (1), pp. 967. Date of Electronic Publication: 2024 Sep 13.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Colistin*/therapeutic use , Colistin*/pharmacology , Acinetobacter baumannii*/drug effects , Acinetobacter Infections*/drug therapy , Acinetobacter Infections*/mortality , Acinetobacter Infections*/microbiology , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Cefiderocol* , Carbapenems*/therapeutic use , Carbapenems*/pharmacology, Humans ; Cephalosporins/therapeutic use ; Drug Resistance, Multiple, Bacterial ; Treatment Outcome

المؤلفون: Massol J; Infectious disease department, Raymond-Poincaré University Hospital, Garches, France. Electronic address: julien.massol@aphp.fr., Dinh A; Infectious disease department, Raymond-Poincaré University Hospital, Garches, France., Jeannot K; Bacteriology department, University Hospital of Besançon, Besançon, France., Duran C; Infectious disease department, Raymond-Poincaré University Hospital, Garches, France., Bouchand F; Pharmacy, Raymond-Poincaré University Hospital, Garches, France., Potron A; Bacteriology department, University Hospital of Besançon, Besançon, France., Dortet L; Microbiology department, University Hospital of Bicêtre, Kremlin Bicêtre, France., Jehl F; Microbiology department, University Hospital of Strasbourg, Strasbourg, France.

المصدر: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2024 Sep; Vol. 38, pp. 140-145. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article; Review; Letter

بيانات الدورية: Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID: 101622459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-7173 (Electronic) Linking ISSN: 22137165 NLM ISO Abbreviation: J Glob Antimicrob Resist Subsets: MEDLINE

مواضيع طبية MeSH: Acinetobacter baumannii*/drug effects , Cefiderocol* , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/administration & dosage , Healthcare-Associated Pneumonia*/drug therapy , Healthcare-Associated Pneumonia*/microbiology , Acinetobacter Infections*/drug therapy , Acinetobacter Infections*/microbiology , Carbapenems*/pharmacology , Carbapenems*/therapeutic use , Cephalosporins*/therapeutic use , Cephalosporins*/administration & dosage , Cephalosporins*/pharmacology, Humans ; Drug Resistance, Multiple, Bacterial ; Cross Infection/drug therapy ; Cross Infection/microbiology

المؤلفون: Kayama S; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Kawakami S; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Kondo K; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Kitamura N; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Yu L; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Hayashi W; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Yahara K; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Sugawara Y; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan., Sugai M; Antimicrobial Resistance Research Centre, National Institute of Infectious Diseases, Higashimurayama City, Tokyo, Japan. Electronic address: sugai@niid.go.jp.

المصدر: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2024 Sep; Vol. 38, pp. 12-20. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID: 101622459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-7173 (Electronic) Linking ISSN: 22137165 NLM ISO Abbreviation: J Glob Antimicrob Resist Subsets: MEDLINE

مواضيع طبية MeSH: beta-Lactamases*/genetics , beta-Lactamases*/metabolism , Cephalosporins*/pharmacology , Cefiderocol* , Bacterial Proteins*/genetics , Bacterial Proteins*/metabolism , Anti-Bacterial Agents*/pharmacology , Meropenem*/pharmacology , Microbial Sensitivity Tests* , Pseudomonas aeruginosa*/drug effects , Pseudomonas aeruginosa*/genetics , Pseudomonas aeruginosa*/enzymology , Gram-Negative Bacteria*/drug effects , Gram-Negative Bacteria*/genetics , Gram-Negative Bacteria*/enzymology , Whole Genome Sequencing* , Acinetobacter*/drug effects , Acinetobacter*/genetics , Acinetobacter*/isolation & purification, Japan ; Humans ; Drug Resistance, Multiple, Bacterial/genetics ; Gram-Negative Bacterial Infections/microbiology ; Azabicyclo Compounds/pharmacology ; Tazobactam/pharmacology ; Drug Combinations ; Imipenem/pharmacology ; Ceftazidime/pharmacology ; Epidemiological Monitoring

المؤلفون: Buyukyanbolu E; Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. nallarecem@gmail.com.; Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA. nallarecem@gmail.com., Genc L; Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey., Cyr EA; Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA., Karakus M; Department of Medical Microbiology, Health Sciences University, Istanbul, Turkey., Comert F; Department of Medical Microbiology, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey., Otlu B; Department of Medical Microbiology, Faculty of Medicine, Inonu University, Malatya, Turkey., Aktas E; Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey., Nicolau DP; Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA.

المصدر: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 Sep; Vol. 43 (9), pp. 1787-1794. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-4373 (Electronic) Linking ISSN: 09349723 NLM ISO Abbreviation: Eur J Clin Microbiol Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Drug Combinations* , Cephalosporins*/pharmacology , Ceftazidime*/pharmacology , Azabicyclo Compounds*/pharmacology , Microbial Sensitivity Tests* , Pseudomonas aeruginosa*/drug effects , Pseudomonas aeruginosa*/isolation & purification , Pseudomonas aeruginosa*/genetics , Pseudomonas aeruginosa*/enzymology , Pseudomonas Infections*/microbiology , Tazobactam*/pharmacology , Anti-Bacterial Agents*/pharmacology , Cefiderocol*, Humans ; Middle Aged ; Female ; Male ; Adult ; beta-Lactamases/genetics ; beta-Lactamases/metabolism ; Aged ; Carbapenems/pharmacology ; Bacterial Proteins/genetics ; Young Adult ; Adolescent ; beta-Lactamase Inhibitors/pharmacology ; Child

المؤلفون: Jean-Pierre V; Service de Microbiologie et Hygiène hospitalière, HydroSciences Montpellier, Univ. Montpellier, CNRS, IRD, CHU de Nîmes, Montpellier, 34093, France., Sorlin P; CPias Loire Atlantique, CHU de Nantes, Nantes, 44093, France., Jeannot K; Laboratoire associé du Centre National de Référence de la Résistance aux Antibiotiques, CHU de Besançon, Besançon, 25000, France., Chiron R; Centre de Ressources et de Compétences de la Mucoviscidose, HydroSciences Montpellier, Univ. Montpellier, CNRS, IRD, CHU de Montpellier, Montpellier, 34093, France., Lavigne JP; Service de Microbiologie et Hygiène hospitalière, VBIC, INSERM U1047, Univ. Montpellier, CHU de Nîmes, Nîmes, 30900, France., Pantel A; Service de Microbiologie et Hygiène hospitalière, VBIC, INSERM U1047, Univ. Montpellier, CHU de Nîmes, Nîmes, 30900, France., Marchandin H; Service de Microbiologie et Hygiène hospitalière, HydroSciences Montpellier, Univ. Montpellier, CNRS, IRD, CHU de Nîmes, Montpellier, 34093, France. helene.marchandin@umontpellier.fr.

المصدر: Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2024 Aug 22; Vol. 23 (1), pp. 78. Date of Electronic Publication: 2024 Aug 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711 (Electronic) Linking ISSN: 14760711 NLM ISO Abbreviation: Ann Clin Microbiol Antimicrob Subsets: MEDLINE

مواضيع طبية MeSH: Achromobacter*/drug effects , Microbial Sensitivity Tests*/methods , Anti-Bacterial Agents*/pharmacology , Cephalosporins*/pharmacology , Cefiderocol*, Humans ; Gram-Negative Bacterial Infections/microbiology

المؤلفون: Egge SL; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Medicine, Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA., Rizvi SA; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA., Simar SR; UTHealth Houston School of Public Health, University of Texas Health Science Center, Houston, Texas, USA., Alcalde M; Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clinica Alemana, Universidad del Desarrollo and Multidisciplinary Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile.; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen Macarena, CSIC, Universidad de Sevilla, Seville, Spain., Martinez JRW; Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clinica Alemana, Universidad del Desarrollo and Multidisciplinary Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile., Hanson BM; UTHealth Houston School of Public Health, University of Texas Health Science Center, Houston, Texas, USA., Dinh AQ; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA., Baptista RP; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Tran TT; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Shelburne SA; Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Munita JM; Instituto de Ciencias e Innovación en Medicina (ICIM), Facultad de Medicina Clinica Alemana, Universidad del Desarrollo and Multidisciplinary Initiative for Collaborative Research On Bacterial Resistance (MICROB-R), Santiago, Chile., Arias CA; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Hakki M; Department of Medicine, Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA., Miller WR; Division of Infectious Diseases, Houston Methodist Hospital, Houston, Texas, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Aug 07; Vol. 68 (8), pp. e0012724. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Pseudomonas aeruginosa*/genetics , Pseudomonas aeruginosa*/drug effects , Microbial Sensitivity Tests* , Anti-Bacterial Agents*/pharmacology , Mutation* , Bacterial Proteins*/genetics , Cefiderocol*, Humans ; Cephalosporins/pharmacology ; Membrane Proteins/genetics ; Pseudomonas Infections/microbiology ; Pseudomonas Infections/drug therapy ; Drug Resistance, Bacterial/genetics

عنوان ترانسليتريتد: Cefiderocol utilization in lung transplant recipients at a single center.

المؤلفون: Persaud PN; Cleveland Clinic Foundation, Department of Internal Medicine, Cleveland, Ohio, USA., Xhemali X; Clevleand Clinic Foundation, Department of Pharmacy, Cleveland, Ohio, USA., Neuhaus K; Clevleand Clinic Foundation, Department of Pharmacy, Cleveland, Ohio, USA., Budev M; Cleveland Clinic Foundation, Department of Pulmonary Medicine, Cleveland, Ohio, USA., Lum J; Cleveland Clinic Foundation, Department of Infectious Disesaes, Cleveland, Ohio, USA.

المصدر: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2024 Aug; Vol. 26 (4), pp. e14319. Date of Electronic Publication: 2024 Jun 17.

نوع المنشور: English Abstract; Journal Article

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3062 (Electronic) Linking ISSN: 13982273 NLM ISO Abbreviation: Transpl Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Lung Transplantation*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Pseudomonas Infections*/drug therapy , Pseudomonas aeruginosa*/drug effects , Cefiderocol* , Cephalosporins*/therapeutic use , Drug Resistance, Multiple, Bacterial* , Transplant Recipients*/statistics & numerical data, Humans ; Retrospective Studies ; Middle Aged ; Female ; Male ; Adult ; Aged ; Microbial Sensitivity Tests

المؤلفون: Pasteran F; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Wong O; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, USA., Mezcord V; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, USA., Lopez C; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Georgeos N; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Fua V; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Ozuna A; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Ramlaoui D; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Sánchez C; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Marchetti P; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Corso A; Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, Antimicrobial Service of the National Institute of Infectious Diseases (ANLIS Dr. Carlos G. Malbrán), Buenos Aires, Argentina., Tolmasky ME; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, USA., Bonomo RA; Research Service and Geriatric Research Education and Clinical Center (GRECC), Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, USA; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Case Western Reserve University (CWRU)-Cleveland Veterans Affairs Medical Center (VAMC) Center for Antimicrobial Resistance and Epidemiology, Case VA Center for Antimicrobial Resistance and Epidemiology (CARES), Cleveland, OH, USA., Ramirez MS; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA, USA. Electronic address: msramirez@fullerton.edu.

المصدر: Journal of microbiological methods [J Microbiol Methods] 2024 Aug; Vol. 223, pp. 106972. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: Netherlands NLM ID: 8306883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8359 (Electronic) Linking ISSN: 01677012 NLM ISO Abbreviation: J Microbiol Methods Subsets: MEDLINE

مواضيع طبية MeSH: Microbial Sensitivity Tests*/methods , Acinetobacter*/drug effects , Anti-Bacterial Agents*/pharmacology , Cephalosporins*/pharmacology , Cefiderocol*, Humans ; Acinetobacter Infections/microbiology